CDT Equity Inc

CDT Equity Inc has a negative equity position of -$3.1 million and a debt-to-equity ratio of -0.32, indicating a leveraged capital structure with liabilities exceeding assets. The company's liquidity position is rated as medium, with a current ratio of 1.59, suggesting it can cover short-term obligations but with limited buffer. The enterprise value to EBITDA ratio is -3.39, reflecting the company's unprofitable operations and negative cash flows. Profitability metrics show significant underperformance relative to industry norms. The company reported a net loss of $3.55 million and an operating loss of $2.96 million in the latest period. Return on equity is 1.15%, while return on assets is -0.72%, both well below the industry median for diagnostic companies. The negative operating cash flow of $2.36 million highlights ongoing cash burn that requires close monitoring. Geographic and segment exposure data is not available in the current dataset, but the company's business model suggests a focus on domestic diagnostic services with potential regional concentration risks. No specific revenue concentration metrics are disclosed, but the negative equity position implies potential overexposure to a single market or customer segment. The company's growth trajectory is constrained by its current financial position. With a market cap of $9.04 million and negative operating income, CDT lacks the financial capacity for meaningful expansion without external financing. The risk assessment indicates low dilution potential, but the negative net cash position after subtracting total debt suggests potential capital raising needs. Recent filings and transcripts are not available in the current dataset, but the company's financial statements show consistent operating losses and negative cash flows. The ESG profile reveals a C+ rating with particular weaknesses in the environment pillar, which could impact long-term sustainability. The company's risk profile is shaped by its unprofitable operations and negative equity position. While dilution risk is currently low, the negative net cash position after debt suggests potential capital raising needs that could increase dilution risk in the future. The ESG controversies score of 100 indicates no current controversies, but the low environment pillar score suggests potential regulatory risks in the healthcare diagnostics sector.